[1] | Berk M., Williams L.J., Jacka F.N., O'Neil A., Pasco J.A., Moylan S., Allen N.B., Stuart A.L., Hayley A.C., Byrne M.L., Maes M. So depression is an inflammatory disease, but where does the inflammation come from? BMC Med. 2013; 11: 200. [PMC free article] [PubMed] [Google Scholar] |
[2] | Chirumbolo A., Callea A., Urbini F. The effect of job insecurity and life uncertainty on Everyday consumptions and broader life projects during COVID-19 pandemic. Int. J. Environ. Res. Publ. Health. 2021; 18 doi: 10.3390/ijerph18105363. [PMC free article] [PubMed] [CrossRef] [Google Scholar] |
[3] | Daher A., Cornelissen C., Hartmann N.-U., Balfanz P., Müller A., Bergs I., Aetou M., Marx N., Marx G., Simon T.-P., Müller-Wieland D., Hartmann B., Kersten A., Müller T., Dreher M. Six months follow-up of patients with invasive mechanical ventilation due to COVID-19 related ARDS. Int. J. Environ. Res. Publ. Health. 2021; 18 doi: 10.3390/ijerph18115861. [PMC free article] [PubMed] [CrossRef] [Google Scholar] |
[4] | Ettman C.K., Abdalla S.M., Cohen G.H., Sampson L., Vivier P.M., Galea S. Prevalence of depression symptoms in US adults before and during the COVID-19 pandemic. JAMA Netw Open. 2020;3 [PMC free article] [PubMed] [Google Scholar] |
[5] | Ho C.S.H., Chee C.Y.I., Ho R.C.M. Mental health strategies to combat the psychological impact of Coronavirus disease 2019 (COVID-19) beyond paranoia and panic. Ann. Acad. Med. Singapore. 2020; 49: 155–160. [PubMed] [Google Scholar] |
[6] | Huang Y., Pinto M.D., Borelli J.L., Mehrabadi M.A., Abrihim H., Dutt N., Lambert N., Nurmi E.L., Chakraborty R., Rahmani A.M., Downs C.A. 2021. COVID Symptoms, Symptom Clusters, and Predictors for Becoming a Long-Hauler: Looking for Clarity in the Haze of the Pandemic. medRxiv. [CrossRef] [Google Scholar] |
[7] | GBD 2016 Disease and Injury Incidence and Prevalence Collaborators Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017; 390: 1211–1259. [PMC free article] [PubMed] [Google Scholar] |
[8] | Liu Y., Ho R.C.-M., Mak A. Interleukin (IL)-6, tumour necrosis factor alpha (TNF-α) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: a meta-analysis and meta-regression. J. Affect. Disord. 2012 doi: 10.1016/j.jad.2011.08.003. [PubMed] [CrossRef] [Google Scholar] |
[9] | Liu D., Baumeister R.F., Zhou Y. Mental health outcomes of coronavirus infection survivors: a rapid meta-analysis. J. Psychiatr. Res. 2021; 137: 542–553. [PMC free article] [PubMed] [Google Scholar] |
[10] | Lu Y., Ho C.S., Liu X., Chua A.N., Wang W., McIntyre R.S., Ho R.C. Chronic administration of fluoxetine and pro-inflammatory cytokine change in a rat model of depression. PLoS One. 2017; 12 [PMC free article] [PubMed] [Google Scholar] |
[11] | Mattioli F., Stampatori C., Righetti F., Sala E., Tomasi C., De Palma G. Neurological and cognitive sequelae of Covid-19: a four month follow-up. J. Neurol. 2021 doi: 10.1007/s00415-021-10579-6. [PMC free article] [PubMed] [CrossRef] [Google Scholar] |
[12] | Mazza M.G., De Lorenzo R., Conte C., Poletti S., Vai B., Bollettini I., Melloni E.M.T., Furlan R., Ciceri F., Rovere-Querini P., COVID-19 BioB Outpatient Clinic Study group, Benedetti, F. Anxiety and depression in COVID-19 survivors: role of inflammatory and clinical predictors. Brain Behav. Immun. 2020; 89: 594–600. [PMC free article] [PubMed] [Google Scholar] |
[13] | Writing Committee for the COMEBAC Study Group. Morin L., Savale L., Pham T., Colle R., Figueiredo S., Harrois A., Gasnier M., Lecoq A.-L., Meyrignac O., Noel N., Baudry E., Bellin M.-F., Beurnier A., Choucha W., Corruble E., Dortet L., Hardy-Leger I., Radiguer F., Sportouch S., Verny C., Wyplosz B., Zaidan M., Becquemont L., Montani D., Monnet X. Four-month clinical status of a cohort of patients after hospitalization for COVID-19. J. Am. Med. Assoc. 2021; 325: 1525–1534. [PMC free article] [PubMed] [Google Scholar] |
[14] | Nasserie T., Hittle M., Goodman S.N. Assessment of the frequency and variety of persistent symptoms among patients with COVID-19: a systematic review. JAMA Netw Open. 2021;4 [PMC free article] [PubMed] [Google Scholar] |
[15] | Page M.J., McKenzie J.E., Bossuyt P.M., Boutron I., Hoffmann T.C., Mulrow C.D., Shamseer L., Tetzlaff J.M., Akl E.A., Brennan S.E., Chou R., Glanville J., Grimshaw J.M., Hróbjartsson A., Lalu M.M., Li T., Loder E.W., Mayo-Wilson E., McDonald S., McGuinness L.A., Stewart L.A., Thomas J., Tricco A.C., Welch V.A., Whiting P., Moher D. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. PLoS Med. 2021;18 [PMC free article] [PubMed] [Google Scholar] |
[16] | Parker G., Brotchie H. Gender differences in depression. Int. Rev. Psychiatr. 2010; 22: 429–436. [PubMed] [Google Scholar] |
[17] | Pieh C., Budimir S., Probst T. The effect of age, gender, income, work, and physical activity on mental health during coronavirus disease (COVID-19) lockdown in Austria. J. Psychosom. Res. 2020; 136: 110186. [PMC free article] [PubMed] [Google Scholar] |
[18] | Sepúlveda-Loyola W., Rodríguez-Sánchez I., Pérez-Rodríguez P., Ganz F., Torralba R., Oliveira D.V., Rodríguez-Mañas L. Impact of social isolation due to COVID-19 on health in older people: mental and physical effects and recommendations. J. Nutr. Health Aging. 2020; 24: 938–947. [PMC free article] [PubMed] [Google Scholar] |